Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Core Binding Factor Alpha 2 Subunit | 4 | 2023 | 34 | 2.090 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2023 | 353 | 0.780 |
Why?
|
| Leukemia | 1 | 2023 | 376 | 0.690 |
Why?
|
| Ubiquitination | 2 | 2018 | 172 | 0.630 |
Why?
|
| Repressor Proteins | 5 | 2024 | 811 | 0.570 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 197 | 0.500 |
Why?
|
| Carrier Proteins | 1 | 2018 | 1021 | 0.430 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2021 | 537 | 0.300 |
Why?
|
| Protein Stability | 2 | 2018 | 167 | 0.290 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2022 | 532 | 0.250 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2024 | 20 | 0.240 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2022 | 61 | 0.200 |
Why?
|
| Immunity, Innate | 1 | 2024 | 374 | 0.200 |
Why?
|
| Leukemia, Myeloid | 2 | 2020 | 85 | 0.190 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 2 | 2018 | 2 | 0.180 |
Why?
|
| Mutation | 3 | 2024 | 5778 | 0.170 |
Why?
|
| Homeodomain Proteins | 2 | 2020 | 544 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2020 | 98 | 0.170 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2019 | 16 | 0.170 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 41 | 0.170 |
Why?
|
| Cytoplasm | 1 | 2019 | 289 | 0.160 |
Why?
|
| Methyltransferases | 1 | 2019 | 71 | 0.160 |
Why?
|
| Erythroid Cells | 1 | 2018 | 27 | 0.160 |
Why?
|
| K562 Cells | 1 | 2018 | 95 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 4268 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 56 | 0.150 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2018 | 64 | 0.150 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 110 | 0.150 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2019 | 137 | 0.150 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 573 | 0.140 |
Why?
|
| Atherosclerosis | 1 | 2024 | 828 | 0.140 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 619 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 2533 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2018 | 328 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 467 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2019 | 715 | 0.120 |
Why?
|
| Calcium | 1 | 2019 | 1096 | 0.120 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1916 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2024 | 4508 | 0.120 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 2048 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2024 | 459 | 0.090 |
Why?
|
| Biomarkers | 1 | 2019 | 2943 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 2577 | 0.090 |
Why?
|
| Humans | 9 | 2024 | 123199 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3098 | 0.090 |
Why?
|
| Mice | 6 | 2024 | 17498 | 0.080 |
Why?
|
| HeLa Cells | 2 | 2021 | 809 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 4352 | 0.070 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 251 | 0.070 |
Why?
|
| Animals | 6 | 2024 | 33741 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2024 | 48 | 0.060 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2024 | 119 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1684 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2308 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3289 | 0.050 |
Why?
|
| Monocytes | 1 | 2024 | 347 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2024 | 197 | 0.050 |
Why?
|
| THP-1 Cells | 1 | 2021 | 22 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2021 | 31 | 0.050 |
Why?
|
| Macrophages | 1 | 2024 | 607 | 0.050 |
Why?
|
| Colony-Forming Units Assay | 1 | 2020 | 68 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2020 | 53 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2022 | 571 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2020 | 330 | 0.040 |
Why?
|
| Hematopoiesis | 1 | 2021 | 220 | 0.040 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 258 | 0.040 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 645 | 0.040 |
Why?
|
| Whole-Body Irradiation | 1 | 2018 | 65 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2018 | 40 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2020 | 612 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 353 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 268 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 762 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2024 | 3717 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1239 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2018 | 322 | 0.030 |
Why?
|
| Gene Editing | 1 | 2018 | 187 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 742 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 2391 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 576 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2018 | 1470 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1783 | 0.030 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1431 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1875 | 0.020 |
Why?
|
| Male | 3 | 2024 | 60021 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4509 | 0.020 |
Why?
|
| Female | 3 | 2021 | 65432 | 0.020 |
Why?
|